Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 17, 2015 - Issue 4
Submit an article Journal homepage
830
Views
5
CrossRef citations to date
0
Altmetric
Original Research Report

Heredity of port-wine stains: Investigation of families without a RASA1 mutation

Agneta Troilius RubinDepartment of Dermatology, Laser & Vascular Anomaly, Skåne University Hospital, Malmoe, SwedenCorrespondence[email protected]
,
Edgar LauritzenDermatologic Clinic, Copenhagen, Denmark
,
Bo LjunggrenDepartment of Dermatology, Laser & Vascular Anomaly, Skåne University Hospital, Malmoe, Sweden
,
Nicole RevencuLaboratory of Human Molecular Genetics, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium;Center for Laser & Vascular Anomalies, Cliniques Universitaires Saint-Luc, Brussels, Belgium;Center for Human Genetics, Cliniques Universitaires Saint-Luc, Brussels, Belgium
,
Mikka VikkulaLaboratory of Human Molecular Genetics, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium;Center for Laser & Vascular Anomalies, Cliniques Universitaires Saint-Luc, Brussels, Belgium;Center for Human Genetics, Cliniques Universitaires Saint-Luc, Brussels, Belgium
&
Åke SvenssonDepartment of Dermatology, Laser & Vascular Anomaly, Skåne University Hospital, Malmoe, Sweden
Pages 204-208 | Received 04 Feb 2014, Accepted 05 Jan 2015, Published online: 12 Mar 2015

References

  • Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976;58:218–222.
  • Barsky SH, Rosen S, Geer DE, Noe JM. The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol. 1980;74:154–157.
  • Smoller BR, Rosen S. Port-wine stains. A disease of altered neural modulation of blood vessels? Arch Dermatol. 1986;122:177–179.
  • Rydh M, Malm M, Jernbeck J, Dalsgaard CJ. Ectatic blood vessels in port-wine stains lack innervation: Possible role in pathogenesis. Plast Reconstr Surg. 1991;87:419–422.
  • Osburn K, Schosser RH, Everett MA. Congenital pigmented and vascular lesions in newborn infants. J Am Acad Dermatol. 1987;16:788–792.
  • Mills CM, Lanigan SW, Hughes J, Anstey AV. Demographic study of port wine stain patients attending a laser clinic: family history, prevalence of naevus anaemicus and results of prior treatment. Clin Exp Dermatol. 1997;22:166–168.
  • Van der Horst CMAM, van Eijk TGJ, de Borgie CAJM, Koster PHL, Struycken PM, Strackee SD. Hereditary port-wine stains, do they exist? Lasers Med Sci. 1999;14:238–243.
  • Troilius A. Characterisation and treatment of patients with port wine stains with special reference to the emotional impact. PhD thesis, Lund University, Lund, Sweden, 1999.
  • Troilius A, Wrangsjo B, Ljunggren B. Patients with port-wine stains and their psychosocial reactions after photothermolytic treatment. Dermatol Surg. 2000;26:190–196.
  • Eerola I, Boon LM, Watanabe S, Grynberg H, Mulliken JB, Vikkula M. Locus for susceptibility for familial capillary malformation (‘port-wine stain’) maps to 5q. Eur J Hum Genet. 2002;10:375–380.
  • Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, et al. Capillary malformation–arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73:1240–1249.
  • Breugem CC, Alders M, Salieb-Beugelaar GB, Mannens MM, Van der Horst CM, Hennekam RC. A locus for hereditary capillary malformations mapped on chromosome 5q. Hum Genet. 2002;110:343–347.
  • Boon LM, Mulliken JB, Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev. 2005;15:265–269.
  • Klapman MH, Yao JF. Thickening and nodules in port-wine stains. J Am Acad Dermatol. 2001;44:300–302.
  • Sanchez-Carpintero I, Mihm MC, Mizeracki A, Waner M, North PE. Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: Morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol. 2004;50:608–612.
  • Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375–423.
  • Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87:1181–1190.
  • Limaye N, Wouters V, Uebelhoer M, Tuominen M, Wirkkala R, Mulliken JB, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41:118–124.
  • Brouillard P, Boon LM, Mulliken JB, Enjolras O, Ghassibé M, Warman ML, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet. 2002;70:866–874.
  • Thiex R, Mulliken JB, Revencu N, Boon LM, Burrows PE, Cordisco M, et al. A novel association between RASA1 mutations and spinal arteriovenous anomalies. AJNR Am J Neuroradiol. 2010;31:775–779.
  • Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008;29:959–965.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.